TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04981678

The Effect of Buprenorphine Continuation for Patients With Opioid Use Disorder

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“This study was halted prior to accumulating the full number of participants due to difficulty in recruiting study subjects.”

The sponsor’s own words in the registry.

Life of this trial

20212022202320242025Registered2021-07-08Started2022-01-01Primary completion2023-09-15Stopped2023-10-16Results posted2024-12-13

Vital statistics

Status
Terminated
Phase
Phase 4
Sponsor
MaineHealth
Sponsor type
University, hospital or other
Conditions
Opioid-use Disorder
Interventions
Buprenorphine; Buprenorphine
Participants
12
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.